Choosing the Right In Vivo Study Path for Preclinical Drug Development
Whether you're an established biotech or pharma organization or nearing your start-up launch, selecting how and where to conduct your in vivo studies is a pivotal step in your preclinical drug development. The approach you choose will impact timelines, costs, and data.
Our new resource, "Choosing the Right In Vivo Study Execution Path: A Guidebook for Preclinical Drug Developers," outlines the four options for conducting in vivo studies:
- Academic labs and partnerships
- Contract Research Organizations (CROs)
- Private vivarium builds
- Rentable vivarium spaces
Each option offers unique advantages and considerations based on your needs, resources, and expertise. Whether you prioritize cost-effectiveness, specialized expertise, or control over in vivo study execution, understanding these pathways is essential for informed decision-making.
By carefully evaluating your research objectives and constraints, you can choose the in vivo study path that aligns with your development goals at each phase.
Download our in vivo execution guide to determine your best option today and for the future.